Fragment-Based Approach towards the Design of Potent and Versatile Anti-Cancer Agents

Sana Ali Zahra et al. (Dec 2020)

Despite years of clinical research and trials of encouraging new therapies, cancer remains a leading cause of morbidity and mortality. The fragment-based drug discovery has evolved formerly as an e...

Pharmacokinetic Modeling Concepts: Compartmental and Non-compartmental approach for Drug Designing

Duaa Aslam Chaudhry et al. (Dec 2016)

Pharmacokinetic modeling helps to estimate the ADME parameters of all the natural and synthetic drug substances in humans and animals. There are two types of approaches for predicting the kinetic p...

Evaluation Of The Anti-Inflammatory Pharmacological Effects Of Artemisia Annua Extracts Artemisinin In Vitro And In Vivo

Muhammad Saqib et al. (Jun 2023)

Artemisia annua L. is ackno...

A Literature Review of the Physicochemical, Physiological and Pharmaceutical Considerations in GIT Absorption of Drugs.

Rabia Mazhar et al. (Dec 2017)

Oral route of drug administration is the most common among all routes and hence their pharmacokinetic and pharmacodynamic factors are substantial to study. Among such factors, GIT absorption is the...

A Comprehensive Insight on Pharmacokinetics

Urooj Naseem et al. (Dec 2016)

Pharmacokinetics can be defined as what the body does to a drug. The basic parameters of pharmacokinetics are discussed here including absorption, distribution, metabolism, and excretion. Character...

• Eason, C. T., Bonner, F. W., & Parke, D. V. (1990). The importance of pharmacokinetic and receptor studies in drug safety evaluation. Regulatory Toxicology and Pharmacology, 11(3), 288-307.
• Foti, R. S. et al (2015).
• Danhof, M. (2015). Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models. J. Pharmacokinet. Pharmacodyn. 42, 447- 462
• Jones, H. M., Mayawala, K. & Poulin, P. (2013). Dose selection based on physiologically based pharmacokinetic (PBPK) approaches. AAPS J. 15, 377- 387.
• Morgan, P. et al (2012). Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival. Drug Discov. Today. 17, 419- 424.
• Rowland M, Benet, L. Z., & Graham, G. G. (1973). Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm. 1(2):123-36.
• Rowland, M., Lesko, L. J. & Rostami-Hodjegan. (2015). A. Physiologically based pharmacokinetics is impacting drug development and regulatory decision making. CPT Pharmacometrics Syst. Pharmacol. 4, 313-315.

• 
  
  
  Figure 1
• 
  
  
  Figure 2
• 
  
  
  Figure 3
• 
  
  
  Figure 4
• 
  
  
  Figure 5
• 
  
  
  Figure 6
• 
  
  
  Figure 7